Background. Healthcare-associated infections (HAI) are a significant cause of morbidity and mortality for patients and continue to be an area of focus for public health programs. In the era of mandatory reporting, hospital infection prevention and control (IPC) departments are responsible for HAI data collection and management. Enumeration of infection and denominator data is often a manual and time-intensive process, which increases the potential for errors. In 2014, IPC and data analytics departments partnered to optimize data collection/reporting through the creation of a QlikView™ application, the Infection Control Dashboard (ICD).
Background. Surveillance for asymptomatic carriage of multidrug-resistant (MDR) pathogens is useful to determine the burden of these organisms and help guide infection prevention strategy. We currently perform surveillance cultures for Gramnegative multidrug-resistant pathogens (GNMDR) in the ICUs on a monthly basis. We added a quarterly point prevalence survey to all hospital units for these and other key pathogens over one year to determine whether our program should expand beyond the ICU and include other organisms.
Methods. Rectal samples were collected quarterly for 1 year starting June 2016 at NorthShore University HealthSystem, a four-hospital, 789 bed system. All hospitalized patients present on the day of the point prevalence testing had a double-headed rectal swab collected. One swab was plated to VACC agar (Remel) for culture of GNMDR and VRE, and the second was plated to CCFAHT (Anaerobe Systems) for C. difficile (Cdif) culture. All samples were collected on a specified day at each of our 4 hospitals, one hospital per week, and sent to the central microbiology lab for processing. Testing for GNMDR included the following pathogens: Carbapenem-resistant Enterobacteriaceae (CRE), ESBLs, and Gram negative organisms susceptible to ≤2 drug classes.
Results. A total of 987 surveillance samples were collected. The number of patients with MDR in the ICU vs. non-ICU units is described in Table 1 . There was an 11% greater difference in the percentage of patients colonized with GNMDR and Cdif in non-ICU patients compared with ICU patients (P = 0.006). An important discovery was three patients colonized with CRE outside the ICU that were previously unknown. The burden of ESBL, VRE and Cdif carriage was also greater outside the ICU. Background. In 2015, the Centers for Disease Control and Prevention (CDC) and the Centers for Medicare and Medicaid Services (CMS) reminded hospitals of the importance of using standardized surveillance definitions to report healthcare-associated infections (HAIs). Concerns remain, however, about how hospitals apply these definitions.
Methods. We performed a survey via the Society for Healthcare Epidemiology of America's Research Network exploring reporting differences for central line-associated bloodstream infection (CLABSI) in U.S. hospitals. Three patient scenarios were presented, and respondents were asked to determine whether the infection was a CLABSI reportable to the CDC's National Healthcare Safety Network (NHSN), a secondary bloodstream infection, or an infection present on admission. Hospitals were also asked how they adjudicate cases when having a difficult time determining the type of infection, including whether hospitals contact NHSN, ask for physician or committee guidance on HAI determination, or rely solely upon NHSN definitions.
Results. We sent the survey to 88 U.S. hospitals and received a response from 42 (48%). The respondents included 32 infection preventionists (IPs) and 10 non-IPs involved in infection prevention. Respondents correctly classified the case 79.4% of the time (100 out of 126 reviewed scenarios, 3 per respondent), assigned an attribution that would have led to under-reporting 14.3% of the time (18/126), and assigned an attribution that would have led to over-reporting 6.3% of the time (8/126). Respondents from academic medical centers (AMCs) were more likely to accurately report infections with no under reporting (P-value 0.03) than respondents from other types of hospitals. When adjudicating difficult cases, 38/42 (90%) stated that they use the NHSN manual and/or write to NHSN, but physician input (18/42, 43%) or committee input (10/42, 24%) were also common. Of note, 4/42 hospitals (10%) stated that they rely only on physician/committee input.
Conclusion. Our findings suggest variability in the application of NHSN surveillance criteria for CLABSI, with a high reliance on physician or committee review. This appears to result in higher under-reporting by non-AMCs.
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